MAGE-A4 IHC 1F9 pharmDx
Qualitative IHC assay that detects MAGE-A4 protein expression in FFPE synovial sarcoma tissue to determine MAGE-A4 status and support selection of MAGE-A4–directed therapies.
Casandra.ai provides a unified ordering experience so you can request this test directly from the performing lab, without changing your workflow.
Ordering is available where Casandra has an active integration with the performing lab. Labs that offer this test can connect with us to enable digital ordering.
About this test
MAGE-A4 IHC 1F9 pharmDx is an FDA-approved, qualitative immunohistochemistry assay that uses a monoclonal anti–MAGE-A4 antibody to detect nuclear and/or cytoplasmic MAGE-A4 protein expression in FFPE synovial sarcoma tissue. It reports a MAGE-A4 Tumor Intensity Proportion Score (TIPS) to classify specimens as MAGE-A4 positive or negative and help identify patients for MAGE-A4–directed treatment strategies.
Where this test fits
| Indication | Biomarker | Biomarker details | Therapy (Select a therapy to open its FDA-approved testing pathway) |
|---|---|---|---|
| Synovial sarcoma | Melanoma-associated antigen 4 (MAGE-A4) | MAGE-A4 protein overexpression | TECELRA |
IVD Manufacturer
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
Order this test
If your organization is connected to Casandra, you can place an electronic order forMAGE-A4 IHC 1F9 pharmDx directly from your existing workflow.
Casandra connects providers, labs, and sponsored programs so that companion diagnostics can be ordered consistently and documented cleanly, regardless of which system you start from.